MARKETS
Company

Axogen Participates In Series A Funding Round For Trace Biosciences With Additional Investors Expected To Join; Terms Not Disclosed

Jul 29, 2026 · 07:15 AM ET· updated 2h ago

Nerve Trace is a near-infrared fluorescence imaging technology designed to provide direct, real-time visualization of nerves during surgery, including nerves that are otherwise obscured from view by surrounding tissue.

Share
Why It Matters

Axogen is putting money into a company called Trace Biosciences that makes a special camera to help doctors see nerves better during surgery. This shows Axogen believes in new nerve-surgery technology, which could help its business down the road.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.